Oxbow Advisors’s Omega Healthcare OHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.37M | Buy |
+168,256
| New | +$7.68M | 0.63% | 40 |
|
|
2023
Q4 | – | Sell |
-329,547
| Closed | -$10.9M | – | 220 |
|
|
2023
Q3 | $10.9M | Sell |
329,547
-6,095
| -2% | -$195K | 1.72% | 13 |
|
|
2023
Q2 | $10.3M | Sell |
335,642
-772
| -0.2% | -$22.3K | 1.62% | 13 |
|
|
2023
Q1 | $9.22M | Buy |
336,414
+16,232
| +5% | +$452K | 1.65% | 16 |
|
|
2022
Q4 | $8.95M | Sell |
320,182
-3,850
| -1% | -$116K | 1.69% | 16 |
|
|
2022
Q3 | $9.56M | Sell |
324,032
-10,751
| -3% | -$337K | 1.5% | 16 |
|
|
2022
Q2 | $9.44M | Buy |
334,783
+400
| +0.1% | +$11.4K | 1.34% | 19 |
|
|
2022
Q1 | $10.4M | Buy |
334,383
+9,241
| +3% | +$273K | 1.05% | 31 |
|
|
2021
Q4 | $9.62M | Sell |
325,142
-31,692
| -9% | -$925K | 0.92% | 41 |
|
|
2021
Q3 | $10.7M | Buy |
356,834
+42,194
| +13% | +$1.45M | 1.09% | 30 |
|
|
2021
Q2 | $11.4M | Buy |
314,640
+10,045
| +3% | +$373K | 1.19% | 25 |
|
|
2021
Q1 | $11.2M | Sell |
304,595
-4,240
| -1% | -$156K | 1.36% | 21 |
|
|
2020
Q4 | $11.2M | Sell |
308,835
-3,193
| -1% | -$108K | 1.44% | 18 |
|
|
2020
Q3 | $9.34M | Sell |
312,028
-5,268
| -2% | -$164K | 1.19% | 23 |
|
|
2020
Q2 | $9.43M | Buy |
+317,296
| New | +$9.4M | 1.37% | 19 |
|
|
2018
Q3 | – | Sell |
-11,770
| Closed | -$365K | – | 307 |
|
|
2018
Q2 | $365K | Hold |
11,770
| – | – | 0.05% | 223 |
|
|
2018
Q1 | $318K | Sell |
11,770
-124,530
| -91% | -$3.32M | 0.06% | 177 |
|
|
2017
Q4 | $3.75M | Sell |
136,300
-83,357
| -38% | -$2.41M | 0.7% | 43 |
|
|
2017
Q3 | $7.01M | Buy |
219,657
+19,544
| +10% | +$626K | 1.33% | 17 |
|
|
2017
Q2 | $6.61M | Sell |
200,113
-49,848
| -20% | -$1.65M | 1.17% | 19 |
|
|
2017
Q1 | $8.25M | Sell |
249,961
-14,254
| -5% | -$458K | 1.34% | 17 |
|
|
2016
Q4 | $8.26M | Sell |
264,215
-122,388
| -32% | -$3.78M | 1.03% | 25 |
|
|
2016
Q3 | $13.7M | Sell |
386,603
-27,311
| -7% | -$971K | 1.88% | 10 |
|
|
2016
Q2 | $14.1M | Sell |
413,914
-6,307
| -2% | -$210K | 2.01% | 8 |
|
|
2016
Q1 | $14.8M | Sell |
420,221
-14,944
| -3% | -$489K | 2.1% | 7 |
|
|
2015
Q4 | $15.2M | Buy |
435,165
+376,677
| +644% | +$13M | 1.9% | 10 |
|
|
2015
Q3 | $2.06M | Buy |
58,488
+4,314
| +8% | +$151K | 0.34% | 88 |
|
|
2015
Q2 | $1.86M | Sell |
54,174
-1,825
| -3% | -$67K | 0.24% | 109 |
|
|
2015
Q1 | $2.27M | Sell |
55,999
-16,055
| -22% | -$665K | 0.34% | 77 |
|
|
2014
Q4 | $2.81M | Buy |
72,054
+1,158
| +2% | +$43.9K | 0.39% | 65 |
|
|
2014
Q3 | $2.42M | Sell |
70,896
-244
| -0.3% | -$8.98K | 0.34% | 72 |
|
|
2014
Q2 | $2.62M | Sell |
71,140
-1,411
| -2% | -$50.4K | 0.35% | 73 |
|
|
2014
Q1 | $2.43M | Sell |
72,551
-43,113
| -37% | -$1.37M | 0.36% | 72 |
|
|
2013
Q4 | $3.45M | Buy |
115,664
+11,101
| +11% | +$352K | 0.49% | 59 |
|
|
2013
Q3 | $3.12M | Buy |
104,563
+14,377
| +16% | +$437K | 0.5% | 57 |
|
|
2013
Q2 | $2.8M | Buy |
+90,186
| New | +$2.96M | 0.49% | 51 |
|
Other funds holding OHI
VPM
VCM
Oxbow Advisors's OHI Position: Q1 2026 in Review
Oxbow Advisors opened a new position in Omega Healthcare (OHI) in Q1 2026: 168,256 shares worth $7.37M. The stake represents 0.63% of the portfolio and ranks #40 among its holdings. This is a return to the name: Oxbow Advisors previously reported a position in OHI as recently as Q3 2023.
Oxbow Advisors first reported a position in OHI in Q2 2013 and has held it in 36 quarters since. The position peaked at $15.2M in Q4 2015. 742 funds tracked by Wall St. Rank hold OHI as of Q1 2026.
- Oxbow Advisors held 168,256 shares of Omega Healthcare worth $7.37M as of Q1 2026.
- Omega Healthcare was a new Oxbow Advisors position in Q1 2026.
- Omega Healthcare made up 0.63% of Oxbow Advisors's portfolio in Q1 2026, its #40 holding.
- Oxbow Advisors first reported a position in Omega Healthcare in Q2 2013 and has held it in 36 quarters since.
- Oxbow Advisors's Omega Healthcare position peaked at $15.2M in Q4 2015.
- 742 funds tracked by Wall St. Rank held Omega Healthcare as of Q1 2026.
Based on Oxbow Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.